A significant partnership between a leading Victorian university and a top global hospital is poised to elevate MedTech breakthroughs and contribute to the enhancement of healthcare. The Minister for Industry and Innovation, Ben Carroll, witnessed the signing of a Memorandum of Understanding (MoU) between Monash University and Sheba Medical Center in Tel Aviv, Israel. The MoU aims to foster research and development of more inclusive healthcare systems and MedTech manufacturing prospects in Victoria.
The Australian government will provide approximately AU$ 200,000 to Monash University’s Victorian Heart Institute in support of the MoU. The funding will facilitate access to cutting-edge technology, accelerate the adoption of new treatments for cardiovascular diseases, and help combat one of the leading causes of mortality worldwide.
The largest university in Australia, Monash University earned the title of the world’s best in Pharmacy and Pharmacology in 2022, becoming the first Australian institution to achieve this distinction. Meanwhile, Sheba Medical Centre acknowledged as one of the top hospitals globally has gained expertise in artificial intelligence (AI), robotic surgery, digital imaging and telemedicine. These capabilities were established through its in-house innovation hub.
This partnership is anticipated to improve the delivery of healthcare in Victoria and create opportunities for local companies to generate employment in MedTech research, manufacturing, and export.
Australia has extended support to various significant MedTech initiatives, including the Australian Medtech Manufacturing Centre (AU$20 million), mRNA Victoria, and MedTech startups through LaunchVic and the Breakthrough Victoria Fund. Victoria’s MedTech sector contributes AU$ 21.4 billion in revenue, AU$ 3.5 billion in exports and sustains around 31,400 jobs.
The Minister for Industry and Innovation expressed his approval of the partnership between Monash University and Sheba Medical Center, citing its potential to attract more investment to Victoria’s MedTech sector and enhance healthcare for Victorians.
The Minister for Health remarked that partnering with a global leader in digital health innovation such as Sheba Medical Center presents an excellent opportunity for Victoria.
The Deputy Vice-Chancellor of Monash University highlighted the institution’s history of translating research into practical applications, underscoring that the partnership is another step towards improving health outcomes through the integration of research and translation.
The Director-General of Sheba Medical Centre stated that that the partnership aims to advance healthcare and promote economic growth while shifting the future of medicine towards prevention.
The Medical Technology market is expected to generate revenue of approximately US$579.40 billion by 2023. The largest segment of the market is Medical Devices, which is projected to reach a market volume of US$470.60 billion in 2023. Despite a regression in revenues in 2020 due to decreased routine medical treatments apart from COVID-19 treatments, the market has bounced back strongly in 2021. The market is expected to exhibit an annual growth rate of 4.91% between 2023-2027, resulting in a market volume of US$701.90 billion by 2027.
The increasing prevalence of chronic diseases and the emphasis on early diagnosis and treatment by healthcare agencies are among the factors driving growth in the medical technology market. The Medical Technology market is essential to the healthcare sector, with a focus on diagnosing and treating health problems, conducting genetic research and improving physical mobility. Its multifunctional usage and health improvement attributes make it a key player in the industry with steady growth.